Trial intelligence / Profile preview

@home trial of Lybrido and Lybridos in women with female sexual dysfunction using SSRIs

NL-OMON22992Active, not recruiting

Sponsor
Emotional Brain
Start
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of sildenafil + testosterone and Lybridos in female sexual dysfunction (FSD), substance-induced sexual dysfunction, SSRI-induced sexual dysfunction and 2 more, sponsored by Emotional Brain. Primary endpoint: Efficacy on subjective sexual experience in the domestic setting. Started Oct 2008; status: active, not recruiting.

02

Drugs

sildenafil + testosteroneLybridos
03

Conditions

female sexual dysfunction (FSD)substance-induced sexual dysfunctionSSRI-induced sexual dysfunctionhypoactive sexual desire disorder (HSDD)Sexual Arousal Disorder

Beyond the preview

Go deeper on NL-OMON22992.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON22992.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call